GenIP PLC
11 August 2026
GenIP Plc
("GenIP" or the "Company")
New & recurring contract wins
GenIP secures multiple new and recurring contracts for a total consideration of $87k
GenIP plc (AIM: GNIP), a provider of AI-driven services to help research organisations and corporations commercialise their innovations, announces a number of new and recurring contract wins across its key markets for a total consideration of $87k.
Chile
GenIP has further expanded its relationship with Universidad Autónoma de Chile, a long-standing customer of the Company's Invention Evaluator platform, through the purchase of a further 25 Invention Evaluator reports. The University has also invited GenIP to join its Technical Advisory Committee, reinforcing the Company's position as a trusted commercialisation partner and embedding GenIP within one of Chile's leading innovation ecosystems.
Additionally, Gen IP has received a repeat order from an existing university customer for a further 20 Invention Evaluator reports and won a new contract to deliver 15 Invention Evaluator reports for another research university in Chile. This leading research university has a portfolio of approximately 500 technologies, presenting an opportunity for significant future engagement and marks the third customer secured in Chile.
United Kingdom
A leading research university in the UK has reengaged GenIP for a further 12 Invention Evaluation reports. This marks the second time GenIP has been commissioned by this University following an initial purchase of 10 reports last year. The continued expansion of this relationship strengthens GenIP's recurring revenue profile, demonstrates the quality of service delivered and supports management's confidence in the long-term UK growth opportunity.
North America
GenIP continues to experience strong recurring demand from one of North America's leading research universities, which continues to purchase Invention Evaluator reports on a near bi-weekly basis. The consistent level of repeat business highlights the ongoing value delivered by GenIP's technology and demonstrates the potential for long-term recurring revenue from established institutional clients.
Talent Search
GenIP has secured a new Talent Search engagement contract demonstrating the continued diversification of the Company's revenue beyond technology evaluation services. This engagement, together with several additional Talent Search opportunities currently under discussion, reflects the early success of the strategic repositioning of GenIP and supports the Company's strategy of expanding into higher-value, complementary revenue streams.
Melissa Cruz, CEO of GenIP, commented:
"I am pleased with the continued momentum across our key markets, with expanding customer relationships in Chile, the UK and North America demonstrating the growing demand for GenIP's technology commercialisation services.
"The strengthening of our relationship with Universidad Autónoma de Chile, alongside new customer wins in the region, highlights the opportunity for further growth in Latin America. At the same time, repeat engagements in the UK and ongoing demand from North America demonstrate the value of our services and the potential for long-term recurring revenue.
"I am encouraged by the early success of our Talent Search offering, which is broadening our revenue opportunities, while our continued industry engagement is helping to strengthen GenIP's position as a leader in AI-enabled technology commercialisation.
"With a growing international presence and a strong pipeline of opportunities, we remain confident in GenIP's ability to deliver further growth."
For further information regarding GenIP, please visit www.genip.ai, or contact:
|
GenIP Plc Melissa Cruz, CEO |
Via Walbrook PR |
|
|
|
|
Walbrook PR (Financial PR) Alice Woodings William Turner |
Tel: +44 (0)7407 804 654 Tel: +44 (0)7407 020 470 |
|
|
|
|
focusIR (Investor Relations) Kat Perez Dr Paul Cornelius |
Tel: +44 (0)20 4570 2234 Tel: +44 (0)20 4570 2246 |
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.
About GenIP
GenIP is a next-generation business at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.
Service Offerings
GenIP operates through two synergistic service lines:
|
Service |
Description |
Value Proposition |
|
Invention Intelligence Product Suite |
AI-powered market intelligence reports assessing the commercial potential of emerging technologies |
Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy |
|
IP Commercialisation Services |
End-to-end engagement to help research organisations commercialise innovations |
Provides cost-effective, broad support to achieve our clients' strategic objectives |
Together, these services form a unified GenAI-enabled platform for innovation triage and execution.
Vision & Strategy
GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:
· Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.
· Service Deepening Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.
· Strategic Acquisitions Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.